Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage

NCT06119061 is registered in ClinicalTrials.gov with Aaron Cook as lead sponsor.

NCT NCT06119061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Lead sponsor
Aaron Cook
Phase
Phase 4
Overall status
Recruiting
Start date
July 2, 2024
Completion date
December 31, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage, aneurysmal